392 related articles for article (PubMed ID: 26329905)
1. Translational metabolomics in cancer research.
Snyder NW; Mesaros C; Blair IA
Biomark Med; 2015; 9(9):821-34. PubMed ID: 26329905
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics of cancer.
Serkova NJ; Glunde K
Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics toward personalized medicine.
Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
[TBL] [Abstract][Full Text] [Related]
4. Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases.
Mishur RJ; Rea SL
Mass Spectrom Rev; 2012; 31(1):70-95. PubMed ID: 21538458
[TBL] [Abstract][Full Text] [Related]
5. Oncometabolomics in cancer research.
Gupta S; Chawla K
Expert Rev Proteomics; 2013 Aug; 10(4):325-36. PubMed ID: 23992416
[TBL] [Abstract][Full Text] [Related]
6. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.
Sethi S; Hayashi MA; Barbosa BS; Pontes JG; Tasic L; Brietzke E
Adv Exp Med Biol; 2017; 965():265-290. PubMed ID: 28132184
[TBL] [Abstract][Full Text] [Related]
7. Lipidomics applications for disease biomarker discovery in mammal models.
Zhao YY; Cheng XL; Lin RC; Wei F
Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
[TBL] [Abstract][Full Text] [Related]
8. In Situ Metabolomics in Cancer by Mass Spectrometry Imaging.
Buck A; Aichler M; Huber K; Walch A
Adv Cancer Res; 2017; 134():117-132. PubMed ID: 28110648
[TBL] [Abstract][Full Text] [Related]
9. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research.
Emwas AH
Methods Mol Biol; 2015; 1277():161-93. PubMed ID: 25677154
[TBL] [Abstract][Full Text] [Related]
10. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
11. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
Issaq HJ; Waybright TJ; Veenstra TD
Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics in urogenital cancer.
Bujak R; Daghir E; Rybka J; Koslinski P; Markuszewski MJ
Bioanalysis; 2011 Apr; 3(8):913-23. PubMed ID: 21510764
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry.
Yin P; Xu G
Expert Rev Mol Diagn; 2013 May; 13(4):339-48. PubMed ID: 23638817
[TBL] [Abstract][Full Text] [Related]
14. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
[TBL] [Abstract][Full Text] [Related]
15. Key elements of metabolomics in the study of biomarkers of diabetes.
Adamski J
Diabetologia; 2016 Dec; 59(12):2497-2502. PubMed ID: 27714446
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic signature of brain cancer.
Pandey R; Caflisch L; Lodi A; Brenner AJ; Tiziani S
Mol Carcinog; 2017 Nov; 56(11):2355-2371. PubMed ID: 28618012
[TBL] [Abstract][Full Text] [Related]
17. Innovation in metabolomics to improve personalized healthcare.
Cacciatore S; Loda M
Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics: a revolution for novel cancer marker identification.
Bu Q; Huang Y; Yan G; Cen X; Zhao YL
Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
[TBL] [Abstract][Full Text] [Related]
19. The applications of metabolomics in the molecular diagnostics of cancer.
Cheung PK; Ma MH; Tse HF; Yeung KF; Tsang HF; Chu MKM; Kan CM; Cho WCS; Ng LBW; Chan LWC; Wong SCC
Expert Rev Mol Diagn; 2019 Sep; 19(9):785-793. PubMed ID: 31414918
[No Abstract] [Full Text] [Related]
20. Recent advances in metabolomics in oncology.
O'Connell TM
Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
